Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer.
about
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†Comparison of breast cancer survival in two populations: Ardabil, Iran and British Columbia, Canada.Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer.The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort.Guidelines - Inflation or Help in Clinical Routine?Adherence to Treatment Guidelines in Breast Cancer Care - a Retrospective Analysis of the 'Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie'Breast Centers in Germany.Provision of breast cancer care and survival in Germany - results from a population-based high resolution study from Saarland.Pancreatic cancer: surgery is a feasible therapeutic option for elderly patientsFactors affecting survival among women with breast cancer in HawaiiAdjuvant chemotherapy in older women with early-stage breast cancer.Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9,156 patientsModels of care for early-stage breast cancer in CanadaFactors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancerThe impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects.Canadian breast cancer guidelines are as effective as possible under the circumstances.Ethnic differences in breast cancer survival: status and determinants.The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patientsBreast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer.Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?Curricula for teaching the content of clinical practice guidelines to family medicine and internal medicine residents in the US: a survey studyGuideline concordant therapy prolongs survival in HER2-positive breast cancer patients: results from a large population-based cohort of a cancer registryImplementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program.The Ethics of Breast Surgery.Networking for ovarian rare tumors: a significant breakthrough improving disease management.Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients.Which patient- and physician-related factors are associated with guideline adherent initiation of adjuvant endocrine therapy? Results of the prospective multi-centre cohort study BRENDA II.Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy--a representative sample survey in Germany.Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy-results from the prospective multi-center study BRENDA II.In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium.Guidelines are advantageous, though not essential for improved survival among breast cancer patients.Reduction in mortality from breast cancer.Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients.Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region.[Compliance of patients concerning recommended radiotherapy in breast cancer : Association with recurrence, age, and hormonal therapy].The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer.
P2860
Q30317067-646CA744-4D56-4F64-A984-F4665D6BD758Q33513316-3AFE34BB-D13D-4A6B-84D9-F04107F9E885Q33584322-A1CBDA7A-656A-4214-9D6F-0B0C8E3B7EC5Q33772793-DDB11E59-BA66-4B53-BDDD-AAF59691F610Q34096166-EA61BD76-EE74-4D17-9589-2C85642EDDF2Q34096177-9914CE00-3CF0-4293-BEE2-AE5BC7950FEDQ34138350-5BE926B5-1A78-47F8-9409-1F4E4BF5794DQ34423099-D99CEFDD-FF19-40A0-A660-CA7AAADF1EA6Q34576742-996AC170-D058-4531-9467-2F666DB9745AQ34724445-C439CDD8-68D6-4BD1-B1F4-C2BAA184256AQ34858284-D454D395-FF5F-4641-9661-D77220C1D076Q35020541-AEA1DC44-B4B8-4916-A366-F0CD9828CCD6Q35059408-C32C513A-DCB5-4537-ACA2-4DD53DFE32FCQ35535719-A28A3941-5CE7-470B-AAAB-432E2917EA6AQ35611895-61C6163F-C9EF-423A-A100-5F310C6FEAEDQ35659716-A68FD819-6175-41DA-B662-B69ED42B026DQ35668954-5A241BE2-AE26-4C67-8805-B25C72DF0EEBQ35813221-44C9AB1E-C0B1-48AC-8311-A635B9EA10D6Q35815602-553D6DFF-CC6F-42A6-93BB-5A46967417C3Q36269577-8CFB6609-2390-4F24-A637-2D504BE149B8Q37156925-537CDACC-160F-49EF-A181-09FD9417B5CAQ37169342-C2DC8B40-BC91-43CA-9F8E-72A449933013Q37185832-025D26ED-C314-4BF3-9879-2C26EA2CC993Q37366449-032C3CE2-E577-4BED-8B81-15A6C03D7A54Q37687943-08DC460B-54B1-4EC9-A32A-8F2905D3D30FQ37689260-28289B7A-34A2-4608-89A9-37C2164C74F9Q38556204-4AE04C6E-6D89-45CE-954F-B47C46DED1B5Q39234288-2A609312-65EA-4682-B7FE-F356DA8DEE90Q40132081-83E3C8FF-6CF3-4D29-8376-4D7103D7133CQ40747756-F97F5E9D-08FB-4C4F-999E-476EAA85F18BQ40829486-BAAF21D2-EE97-49B1-8441-F13571042362Q40948373-E2EDC9DE-27CA-4614-8494-B4A1BB31425FQ41116986-1A02D9C3-1C2E-40A7-A1B9-286BBA647376Q41645960-C8E47491-646C-4109-B0FB-7A8470B5C091Q42740583-3F0D40ED-3939-4C9A-B92D-EB1F47698E91Q43412230-11704FC3-65B7-4EF9-8672-83F411B00A52Q43737974-D6739A7B-963A-43D8-9366-24EFAE4E1A91Q43838219-EC3B9E83-8288-431F-AEDF-1B9F5CBC3DD3Q44584058-8C66E34B-F921-44B3-882D-E155474C44F4Q44913921-045FABA1-8CF9-4486-A1EC-51CBCBEA62B7
P2860
Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Compliance with consensus reco ...... h node-negative breast cancer.
@ast
Compliance with consensus reco ...... h node-negative breast cancer.
@en
type
label
Compliance with consensus reco ...... h node-negative breast cancer.
@ast
Compliance with consensus reco ...... h node-negative breast cancer.
@en
prefLabel
Compliance with consensus reco ...... h node-negative breast cancer.
@ast
Compliance with consensus reco ...... h node-negative breast cancer.
@en
P2093
P356
P1476
Compliance with consensus reco ...... h node-negative breast cancer.
@en
P2093
Ginette Martin
Jacques Brisson
Jean Latreille
Michèle Rivard
Nadia Abdelaziz
Nicole Hébert-Croteau
P304
P356
10.1200/JCO.2004.07.018
P407
P577
2004-08-02T00:00:00Z